Community news|31/01/22

The CJEU confirms the identification of BPA as an endocrine disruptor for health

Home > The news of EUROGIP and occupational risks in Europe > The CJEU confirms the identification of BPA as an endocrine disruptor for health

The Court of Justice of the European Union (CJEU) has confirmed on appeal the identification of bisphenol A (BPA) as a substance of very high concern(1) for its endocrine disrupting properties for human health.

It has indeed rejected the appeal of the European Plastics Manufacturers’ Association, PlasticsEurope against the judgment of the General Court of the European Union of 20 September 2019, PlasticsEurope/ECHA (T-636/17) in a judgment of 21 December 2021. The European Chemicals Agency (ECHA) had included BPA on the list of candidate substances for authorisation due to its endocrine disrupting properties and potential serious health effects, which the judgment confirms.

As a reminder, PlasticsEurope brought three cases before the European Court of Justice concerning the three hazardous properties of bisphenol A: reproductive toxicity (case T-185/17), endocrine disruptor for human health (case C-876/19 P), and endocrine disruptor for the environment. The first two cases have now been closed with the appeal confirming the correctness of the ECHA decisions. The third is still pending.

(1) Substance of Very High Concern (SVHC) as defined in Regulation 1907/2006 (REACH)

Judgment of the Court of Justice

Discover other news

News, Standardization

30/11/22

AI and OHS: a look back at the Euroshnet conference in October 2022

Artificial Intelligence (AI) meets Occupational Safety and Health (OSH) was the theme of the 7th EUROSHNET conference which took place in Paris on 20 October and which brought together some 130 OSH experts from the world of standardisation, testing and certification, from 15 countries.

Abroad

23/11/22

ITALY: tumour linked to mobile phone use recognised in PM

The Court of Appeal of Turin has just ruled in favour of a 63-year-old former technician who was seeking recognition as an occupational disease of the benign auricular tumour of which he was a victim for having used his mobile phone at work for at least 2.5 hours a day for 13 years.